Fujisawa Pharmaceutical Company, Ltd.

Aktiebolaget Hassle

Yoshiko Yokota

Yasuhiro Mine

Yoshimi Wakai

Hiroshi Kayakiri

Masanori Okamoto

Katsuya Nakamura

Toshio Hattori

Tsutomu Kaizu

Kiyoshi Takatsuki

Yoshimi Matsumoto

Shuichi Tawara

Chizu Morinaga

Yohsuke Maeda

Akiko Ikemoto

Yoshifumi Ikeda

Masaaki Tomoi

The present invention relates to the use of bicozamycins for the prophylaxis and treatment of infections with a verotoxin-producing,, as well as for eradicating verotoxin-producing,in livestock.

Use of bicozamycin for the manufacture of a medicament for treating infections with enterohemorrhagic e. coli

A method for treatment of Lymphadenopathy, AIDS and AIDS related complex which comprises administering FK-565 or its pharmaceutically acceptable salt and AZT.

Composition for prevention and (or) treatment of Aids

Pyrroline compounds of the formulae (I) and (II) are effective in the treatment of retroviral infection and lymphadenopathy. ##STR1##

Antiretroviral agent, method of use thereas, and method of preparation

Use of omeprazole as an antimicrobial agent

A method for treatment of Lymphadenopathy which comprises administering FK-565 or its pharmaceutically acceptable salt and AZT in a ratio of about 1:10-2,000 by weight to an individual in need therefore.

Composition for prevention and (or) treatment of AIDS

This invention relates to a method for combatting viral infections in a mammal comprising administering to the mammal an acylpeptide of the formula ##STR1## wherein R.sup.1 is lactoyl-alanyl, R.sup.2 is carboxymethylamino and R.sup.3 is carboxy; or R.sup.1 is heptanoyl, R.sup.2 is 1-carboxyethylamino and R.sup.3 is carboxy; or R.sup.1 is stearoyl, R.sup.2 is 1-carboxyethylamino and R.sup.3 is hydrogen; or R.sup.1 is octanoyl, R.sup.2 is 1-carboxyethylamino and R.sup.3 is hydrogen.

Method for combatting viral infections

Growing community of inventors

Ibaraki, Japan

Yoshiko Yokota